GLP-1 drugs could cut mortality rates in US and UK, Swiss Re says
Reinsurance News - Sep 18, 2025
Swiss Re, a reinsurance company based in Zurich, has released new research suggesting that GLP-1 weight-loss medications could substantially reduce mortality rates in the United States and the United Kingdom over the next two decades. According to the company’s projections, if these drugs are widely...
Recommended Articles
Posted: Oct 09, 2025
Swiss reinsurer SIGNAL IDUNA Rückversicherungs AG (SI Re) is strengthening its presence in the Spani...
Posted: Oct 09, 2025
Ryan Specialty Holdings, Inc., an international specialty insurance firm, has expanded the roles of...
Posted: Oct 09, 2025
Crystal Venture Partners has closed $33 million Fund I, aimed to back early-stage companies modernis...